Prevalance of Hpv Infection in Women Living with HIV Attending Waibargi Specialist Hospital
Keywords:
Quality improvement, brazil, organ transplantation, management program, PAT-MA, health systems, Maranh, pulmonary hypertension., Chronic thromboembolic pulmonary hypertension, Thrombendarterectomy, Pulmonary vascular resistance, Long-term medical history., HIV, cervical cancer, Screening, CIN, HPVAbstract
Cervical cancer remains a significant public health concern, particularly for women living with HIV (WLWH), due to their increased susceptibility to persistent human papillomavirus (HPV) infections.
This study aims to assess the prevalence of high-risk HPV (hrHPV) infections in WLWH attending Waibargi Specialist Hospital in Myanmar in the year 2024. The cross-sectional analysis involved 234 WLWH, tested with Cobas 4800 system HPV DNA test. Colposcopy directed biopsies were conducted among the participants to detect the presence of cervical intraepithelial neoplasia (CIN) and invasive carcinoma.
The results revealed a high HPV prevalence of 29.9% among the study population, with 70 women tested positive for one or more high-risk HPV types. Among those, single infection with HPV 16 was found in 9 women (3.8%), HPV 18 in 8 (3.4%) while 35 (15%) of them were infected with other high-risk HPV types. Additionally, 18 women (7.7%) had mixed infections involving multiple hrHPV types.
The study also identified that women on ART for more than three years exhibited significantly lower HPV infection rates, as did those with undetectable viral loads, suggesting that effective HIV management can mitigate HPV-related cervical cancer risk.
In this study, 41 women (70.7%) out of 58 HPV-positive cohort diagnosed with CIN I or more severe histological abnormalities after colposcopy directed biopsy. Notably, 86.7% of patients with HPV 16, 18, or mixed infections had positive histology results, compared to 53.6% in those with other hrHPV.
In conclusion, this study highlights the high prevalence of hrHPV infections and the association between specific HPV genotypes and the development of cervical pre cancer and cancer among WLWH. The study also emphasizes the need for integrated cervical cancer screening and vaccination programs within HIV frameworks along with the importance of proper HIV treatment. However, since it is a hospital-based study, further research is required to cover the broader populations, particularly in rural and underserved areas of Myanmar.
References
F Agyare Gyane Agyare Gyane, E Modey Modey, E Maya Maya, E Y Bonney Bonney, A Abaidoo-Myles Abaidoo-Myles (2024) Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana. 19(5), e0303535. https://doi.org/10.1371/journal.pone.0303535
M Ashry Ashry, S Shawky Shawky, Z Mounir Mounir, F Fathy Fathy, H Elsayed Elsayed, W Kamal Kamal, M Hassany Hassany (2024) Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross sectional study. 24(1), 1821. https://doi.org/10.1186/s12889-024-19240-z
L F Bratcher Bratcher, V V Sahasrabuddhe Sahasrabuddhe (2010) The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. https://doi.org/10.1186/1750-9378-5-8
L Bruni Bruni, G Albero Albero, B Serrano Serrano, M Mena Mena, J J Collado Collado, D Gómez Gómez, J Muñoz Muñoz, F X Bosch Bosch, S De Sanjosé De Sanjosé (2023) Human Papillomavirus and Related Diseases in Myanmar.
L Bruni Bruni, M Diaz Diaz, M Castellsagué Castellsagué, E Ferrer Ferrer, F X Bosch Bosch, S De Sanjosé De Sanjosé (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. 202, 1789–99. https://doi.org/10.1086/657321
G Clifford Clifford, S Franceschi Franceschi (2005) HPV in sub-Saharan Africa. 322–326. https://doi.org/10.1179/095741905X49089
J Ferlay Ferlay, M Ervik Ervik, F Lam Lam, M Laversanne Laversanne, M Colombet Colombet, L Mery Mery, M Piñeros Piñeros, A Znaor Znaor, I Soerjomataram Soerjomataram, F Bray Bray (2024) Global Cancer Observatory: Cancer Today. https://gco.iarc.who.int/today
A E Grulich Grulich, M T van Leeuwen van Leeuwen, M O Falster Falster, C M Vajdic Vajdic (2007) Incidence of cancers in people with HIV/AIDS compared with immuno suppressed transplant recipients: A meta-analysis. 59–67. https://doi.org/10.1016/S0140-6736(07)61050-2
(2018) Guideline on secondary prevention of cervical cancer for public sector health facilities.
(2023) Key facts on HIV, Myanmar. https://www.aidsdatahub.org/country-profiles/myanmar
P Mayaud, H A Weiss, C J Lacey, D K Gill, D C Mabey (2003) Genital human papillomavirus genotypes in northwestern Tanzania. 41, 4451–3. https://doi.org/10.1128/JCM.41.9.4451-4453.2003
A Seyoum, N Assefa, T Gure, B Seyoum, A Mulu, A Mihret (2022) Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis. https://doi.org/10.3389/fpubh.2022.890880
M Soto-Salgado, M Ramos-Sepúlveda, J M Ramos-Cartagena, M Tirado-Gómez, H M Guiot, C Muñoz-Massó, L González-Sepúlveda, A P Ortiz (2025) Disparities in the uptake of HPV-related cancer prevention strategies among women by HIV status in Puerto Rico. 57, Article 101687. https://doi.org/10.1016/j.gore.2025.101687
X W Sun, L Kuhn, T V Ellerbrock, et al. (1997) Human papillomavirus infection in women infected with the human immunodeficiency virus. 337((19)), 1343-1349. https://doi.org/10.1056/NEJM199711063371903
K Thorsteinsson, M Storgaard, T L Katzenstein, S Ladelund, F F Rønsholt, I S Johansen, G Pedersen, L Hashemi, L N Nielsen, L Nilas, N Obel, J Bonde, A M Lebech (2016) Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE. https://doi.org/10.1186/s12885-016-2881-1
T Z K Win, K Simms, M M Thinn, K N Tin, S Aung, E Feletto, D Bateson, K Canfell (2025) A Review of Human Papillomavirus Prevalence and Cervical Cancer in Myanmar. 15((1)), 89. https://doi.org/10.1007/s44197-025-00436-4
S Womack, Z M Chirenje, L Gaffikin, et al. (2000) HPV-based cervical cancer screening in a population at high risk for HIV infection. 85((2)), 206-210.
(2021) WHO guideline for screening and treatment of cervical pre cancer lesions for cervical cancer prevention.
(2017) Hospital Statistics (2017-2019), Yangon Central Women's Hospital, Yangon.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
